A picture may be worth a thousand words, but when it comes to disease discovery, Bay Area VC firm Third Rock Ventures is betting its money on moving pictures. But instead of Hollywood blockbusters, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Third Rock Ventures, LLC today announced the formation of Relay Therapeutics with $57 million in Series A financing, including participation from an affiliate of D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback